Kirsten Bibbins-Domingo

@KBibbinsDomingo

Scientist - Physician - Teacher | Professor | Chair | Vice Dean Population Health & Health Equity | Co-Founder

San Francisco, CA
Vrijeme pridruživanja: kolovoz 2010.

Tweetovi

Blokirali ste korisnika/cu @KBibbinsDomingo

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KBibbinsDomingo

  1. Prikvačeni tweet

    Reflecting on the year we’ve had in the Department of Epidemiology & Biostatistics Here are just a few highlights as 2019 draws to a close -

    , , i još njih 5
    Prikaži ovu nit
    Poništi
  2. proslijedio/la je Tweet
    prije 20 sati

    Is it just me or does “public health data science” just sound like a fancy way to say “epidemiology”?

    Poništi
  3. proslijedio/la je Tweet

    Did you know there was been more than doubling of nurse practitioners in the US in just 7 years? , Peter Buerhaus and Douglas Staiger discuss the implications, which include ~80,000 less RNs

    Poništi
  4. proslijedio/la je Tweet
    prije 23 sata

    Interesting point from the Advisory Committee to the "As biomedicine and machine learning fuse, social scientists and humanists can be included from the beginning of projects, to complement technological and biomedical knowledge."

    Poništi
  5. proslijedio/la je Tweet
    4. velj

    Highlighting the crucial importance of boot-leather epidemiology, a paper claiming asymptomatic transmission was wrong because “researchers didn’t actually speak to the woman before they published the paper.” Apparently she was already sick 👇🏼

    Poništi
  6. proslijedio/la je Tweet
    1. velj

    In Epidemiology these days students really do not know how to collect primary data or how to construct a reliable questionnaire. It is our responsibility to ensure they master these basic skills rather than the newest statistical methods.

    Poništi
  7. She Helped a Customer in Need. Then U.S. Bank Fired Her.

    Poništi
  8. proslijedio/la je Tweet
    1. velj

    From : In this pharmacoepidemiology study, use of baclofen in older patients with chronic kidney disease was associated with increased 30-day incidence of encephalopathy

    Poništi
  9. proslijedio/la je Tweet
    1. velj

    SF BUILD Principal Investigators explain why diversity matters in research and biomedical science careers.

    Poništi
  10. proslijedio/la je Tweet

    Immigrant & minority physicians are often in positions to care for frail and vulnerable populations. They often work in communities where others would not. Diversity in the healthcare workforce enriches our ability to address America’s healthcare needs.

    Poništi
  11. proslijedio/la je Tweet
    31. sij

    A packed house for today’s CHOP/IHPI event on using research to impact policy, featuring of , , & , moderated by CHOP Director - follow along in our thread!

    Prikaži ovu nit
    Poništi
  12. proslijedio/la je Tweet
    31. sij

    When interacting with a policymakers “Do not share the limitations of your study,” says . But DO share stories from your experience as a provider or your family, along with your data/ideas, advises .

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    31. sij

    Mark Cullen debating Chuck McCulloch - Big Data vs Randomized Trials. Guess which side he has!!!

    Poništi
  14. Poništi
  15. proslijedio/la je Tweet
    31. sij

    RT : Cert Alert! Mission Hall at UCSF was recently awarded Gold Certification for its great score on its technical review. Congratulations to , , and the project team for the "green" achievement!

    Poništi
  16. Great start to 2020 Bay Area Clinical Symposium - bringing together Can Big Data & Analytics Replace RCTs? Mark Cullen debating Chuck McCulloch – mjesto: Mission Bay Conference Center

    Poništi
  17. proslijedio/la je Tweet
    30. sij

    Great news! receives $10 million gift from school alumnus—our largest ever—strengthening the school's position as a global leader in the health sciences.

    Poništi
  18. proslijedio/la je Tweet
    30. sij

    Community views on CRISPR “The issue of equity will be central in the ethical, legal and social issues in curative gene editing” -Bonham

    Poništi
  19. proslijedio/la je Tweet
    30. sij

    Colleague and friend Vence Bonham from ⁦⁦⁩ ⁦⁩ in his talk on “who will benefit and who will not in genomics”. So lucky to have him ⁦⁩ to ensure a focus on

    Poništi
  20. proslijedio/la je Tweet
    30. sij

    This is quite shocking: Banegas et al. Spanish ABPM Registry Study retracted from NEJM. Curious to learn more FYI

    Prikaži ovu nit
    Poništi
  21. proslijedio/la je Tweet
    30. sij

    7 in 10 Americans have been on Medicaid or had a family on Medicaid.

    Prikaži ovu nit
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·